Abstract
Since response rates in human melanoma are low with currently available therapeutic modalities, we have reevaluated the potential usefulness of retinoids as new alternatives for therapy of metastatic melanoma. Nine synthetic retinoids with high affinity and/or selectivity for the retinoic acid receptors (RAR) α, β, and γ were studied in comparison to all-trans retinoic acid (RA) for their in vitro effects on melanoma cell proliferation and for their immunomodulating capacities using four human melanoma cell lines.
Eight out of ten retinoids tested had no effect on melanoma cell growth, whereas the remaining two compounds with high RAR-γ selectivity (CD437 and CD2325) showed a dose-dependent antiproliferative effect on all melanoma cell lines with IC50 (concentration inhibiting response by 50%) values between 10-6 and 10-7 M. Further analyses showed that paracrine-mediated tumor cell growth inhibition such as induction of transforming growth factor (TGF)-β described as one mechanism of retinoid action and enzyme systems such as tyrosinase and monoamine oxidase were not involved in mediating the antiproliferative effects exerted by the two retinoids. Four of nine retinoids modulated HLA-DR expression on human melanoma cells, and expression levels of intercellular adhesion molecule 1 (ICAM-1) was increased by another subset of compounds. These effects were, however, not correlated to the receptor selectivity of the retinoids.
The potent growth inhibitory effect of the RAR-γ-selective retinoids and the immunomodulating capacities of the retinoids open an interesting alternative for new antiproliferative and immunomodulatory strategies in the treatment of metastatic melanoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bernard BA, Bernadon JM, Delescluse C, Martin B, Lenoir MC, Maignan J, Charpentier B, Pilgrim WR, Reichert U, Shroot B (1992) Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Bio-chem Biophys Res Commun 186:977–983
Bouillon M, Audette M (1993) Transduction of retinoic acid and γ-interferon signal for intercellular adhesion molecule-1 expression on human tumor cell lines: evidence for the late-acting involvement of protein kinase C inactivation. Cancer Res 53:826–832
Bouillon M, Tessier P, Boulianne R, Destrempe R, Audette M (1991) Regulation by retinoic acid of ICAM-1 expression on human tumor cell lines. Biochem Biophys Acta 1097:95–102
Danielpour D, Yip FA, Anzano MA, Smith JM, Sporn MB (1993) Growth inhibition of NRP-152 rat prostatic cells by retinoic acid is mediated via the induction of TGF-βs 2 and 3. Proc Am Assoc Cancer Res 34:128 (abstract)
DeBenedetti F, Falk L, Ruscetti FW, Colburn HN, Faltynek CR, Oppenheim JJ (1991) Synergistic inhibition of phorbol ester induced transformation of JB6 cells by transforming growth factor -ß and retinoic acid. Cancer Res 51:1158–1164
Edward M (1992) Effect of retinoids on tumour invasion and metastasis. Patho-biology 60:271–277
Falkson CI, Falkson G, Falkson HC (1991) Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma. J Clin Oncol 9:1403–1408
Gardner FJE, Walker RA (1993) Modulation of cell surface components of human breast cancer cells by retinioc acid: enhanced HLA-DR expression. J Pathol 170:23–29
Hendrix MJC, Wood R, Seftor EA, Lotan D, Nakajima M, Misiorowski RL, Seftor REB, Stetler-Stevenson WG, Bevacqua SJ, Liotta LA, Sobel ME, Raz A, Lotan R (1990) Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 50:4121–4130
Ho VC, Sober AJ (1990) Therapy of cutaneous melanoma: an update. J Am Acad Dermatol 22:159–176
Lotan R, Hendrix MJC, Lippman SM (1991) Retinoids in the management of melanoma. In: Marks R (ed) Retinoids in cutaneous malignancy, pp 133–149
Jakowlew SB, Mathius A, Zia F, Mulshine JL, Moody TW (1993) Retinoic acid stimulates transforming growth factor-beta mRNAs in non-small cell lung cancer cell lines. Proc Am Assoc Cancer Res 34:21 (abstract)
Martin B, Bernadon JM, Cavey MT, Bernard BA, Carlavan I, Charpentier B, Pilgrim WR, Shroot B, Reichert U (1992) Selective synthetic ligands for human nuclear retinoic acid receptor. Skin Pharmacol 5:57–65
McClay EF, Mastrangelo MJ (1988) Systemic chemotherapy for metastatic melanoma. Semin Oncol 15:569–577
Parsons DG, Favier D, McEwan M, Takahashi H, Jimbow K, Ito S (1991) Action of cysteaminylphenols on human melanoma cells in vivo: 4-S-cysteaminylphenol binds protein disulphide isomerase. Melanoma Res 1:97–104
Reichert U, Bernardon JM, Charpentier B, Nedoncelle P, Martin B, Bernard BA, Asslineau D, Michel S, Lenoir MC, Delescuse C, Pilgrim WM, Darmon YM, Shroot B (1993) Synthetic retinoids: receptor selectivity and biological activity. In: Bernadon BA, Shroot B (eds) From molecular biology to therapeutics. Pharmacol Skin 5:117–127
Richards JM (1991) Sequential chemoimmunotherapy for metastatic melanoma. Semin Oncol 5 [Suppl 7]:91–95
Riley PA (1991) Melanogenesis: a realistic target for antimelanoma therapy? Eur J Cancer 9:1172–1177
Ross AC (1993) Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins. FASEB J 7:317–327
Schadendorf D, Yamaguchi H, Old LJ, Srivastava PK (1989) A novel heteromorphic human cell surface alloantigen, gp60, defined by a human monoclonal antibody. J Immunol 142:1621–1625
Schadendorf D, Tiedemann KH, Haas N, Czarnetzki BM (1991) Detection of human papillomaviruses in paraffin-embedded condylomata — a comparison between immunohistology, in situ hybridization, and polymerase chain reaction. J Invest Dermatol 97:549–554
Schadendorf D, Worm M, Algermissen B, Kohlmus CM, Czarnetzki BM (1994a) Chemosensitivity testing of human malignant melanoma — retrospective analysis of clinical response and in vitro drug sensitivity. Cancer 73:103–108
Schadendorf D, Böhm M, Möller P, Grünewald T, Czarnetzki BM (1994b) Interleukin-7 induces differential lymphokine-activated killer cell activity against human melanoma cells, keratinocytes and endothelial cells. J Invest Dermatol 102:838–842
Schadendorf D, Worm M, Jurgovsky K, Dippel E, Michel S, Charpentier B, Bernardon JM, Reichert U, Czarnetzki BM (1994c) Retinoic acid receptor-8-selective retinoids exert antiproliferative effects on human melanoma cell growth in vitro. Int J Oncol 5 (in press)
Stat Bite (1992) Cancer incidence and mortality trends, 1973–1989. J Natl Inst Cancer 84:1862
Wang Z, Cao Y, D’Urso CM, Ferrone S (1992) Differential suseptibility of human melanoma cell lines to enhancement by retinoic acid of intracellular adhesion molecule 1 expression. Cancer Res 52:4766–4772
Worm M, Schadendorf D, Czarnetzki BM (1993a) Responsiveness to treatment of human melanoma cells correlates to immunophenotype. Melanoma Res 3:29–33
Worm M, Czarnetzki BM, Schadendorf D (1993b) Expression of growth factor receptors on human melanoma cells — comparison of modulating effects of interferons and retinoids. Exp Dermatol 2:217–223
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Schadendorf, D., Worm, M., Jurgovsky, K., Dippel, E., Reichert, U., Czarnetzki, B.M. (1995). Effects of Various Synthetic Retinoids on Proliferation and Immunophenotype of Human Melanoma Cells In Vitro. In: Garbe, C., Schmitz, S., Orfanos, C.E. (eds) Skin Cancer: Basic Science, Clinical Research and Treatment. Recent Results in Cancer Research, vol 139. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78771-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-78771-3_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78773-7
Online ISBN: 978-3-642-78771-3
eBook Packages: Springer Book Archive